| Dr Ayesha Ahmed, MD | |
|
45 S Main St Ste 211, West Hartford, CT 06107-2402 | |
| (860) 478-4341 | |
| (860) 243-3930 |
| Full Name | Dr Ayesha Ahmed |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 35 Years |
| Location | 45 S Main St Ste 211, West Hartford, Connecticut |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487684742 | NPI | - | NPPES |
| 208754101 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 048477 (Connecticut) | Primary |
| Entity Name | Connecticut Mental Health Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053362814 PECOS PAC ID: 0345130563 Enrollment ID: O20040319000165 |
News Archive
A Purdue University-led team of researchers studying the Middle East Respiratory Syndrome, or MERS, have found molecules that shut down the activity of an essential enzyme in the virus and could lead the way to better treatments for those infected.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Mylan Pharmaceutical Inc.'s abbreviated new drug application (ANDA) for Glatiramer Acetate Injection (20 mg/mL), a generic version of Teva's Copaxone(R), a product indicated for the treatment of multiple sclerosis.
In the wake of therecent death of McDonald's Chairman and CEO James Cantalup, it appears thatmore and more people are realizing the importance of taking preventivemeasures to detect health problems before the normal symptoms occur.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign.
› Verified 5 days ago
| Entity Name | Md Care Psychiatric Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104192921 PECOS PAC ID: 2365603545 Enrollment ID: O20120416000245 |
News Archive
A Purdue University-led team of researchers studying the Middle East Respiratory Syndrome, or MERS, have found molecules that shut down the activity of an essential enzyme in the virus and could lead the way to better treatments for those infected.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Mylan Pharmaceutical Inc.'s abbreviated new drug application (ANDA) for Glatiramer Acetate Injection (20 mg/mL), a generic version of Teva's Copaxone(R), a product indicated for the treatment of multiple sclerosis.
In the wake of therecent death of McDonald's Chairman and CEO James Cantalup, it appears thatmore and more people are realizing the importance of taking preventivemeasures to detect health problems before the normal symptoms occur.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ayesha Ahmed, MD 41 Crossroads Plz, # 148, West Hartford, CT 06117-2402 Ph: (860) 478-4341 | Dr Ayesha Ahmed, MD 45 S Main St Ste 211, West Hartford, CT 06107-2402 Ph: (860) 478-4341 |
News Archive
A Purdue University-led team of researchers studying the Middle East Respiratory Syndrome, or MERS, have found molecules that shut down the activity of an essential enzyme in the virus and could lead the way to better treatments for those infected.
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Mylan Pharmaceutical Inc.'s abbreviated new drug application (ANDA) for Glatiramer Acetate Injection (20 mg/mL), a generic version of Teva's Copaxone(R), a product indicated for the treatment of multiple sclerosis.
In the wake of therecent death of McDonald's Chairman and CEO James Cantalup, it appears thatmore and more people are realizing the importance of taking preventivemeasures to detect health problems before the normal symptoms occur.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign.
› Verified 5 days ago
Dr. Kenneth S Robson, M..D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18 N Main St, West Hartford, CT 06107 Phone: 860-561-4178 Fax: 860-561-4183 | |
Mariela Podolski, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 433 S Main St Ste 327, West Hartford, CT 06110 Phone: 860-410-4007 Fax: 860-955-4804 | |
Mr. Arshpreet Singh Gulati, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 65 Kane St, West Hartford, CT 06119 Phone: 860-523-3745 Fax: 860-523-3736 | |
Dr. Brian Christopher Eddy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 22 Hooker Dr, West Hartford, CT 06107 Phone: 860-679-6700 | |
Dr. Harriet A. Fellows, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 23 Woodpond Rd, West Hartford, CT 06107 Phone: 860-989-9100 | |
Dr. Walter Arnold Borden, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 N Main St, West Hartford, CT 06107 Phone: 860-561-1660 Fax: 860-561-1661 | |
Dr. Thomas Michael Hill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 801 Farmington Ave, West Hartford, CT 06119 Phone: 860-232-6951 Fax: 866-394-4132 |